Back to Search
ALESSANDRA FERRAJOLI, M.D.
M.D.
Medical Oncology Physician
NPI: 1952497687IndividualAccepts Medicare
Specialties, Licenses & Credentials
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
L0796(TX)
Education
OTHER
Class of 1988
Research & Publications (20)
Incorporating the use of GM-CSF in the treatment of chronic lymphocytic leukemia.
PMID 19347738·Leuk Lymphoma·2009
3-trial
Pilot experience with continuous infusion alemtuzumab in patients with fludarabine-refractory chronic lymphocytic leukemia.
PMID 18182081·Eur J Haematol·2008
3-trial
Lenalidomide induces complete and partial remissions in patients with relapsed and refractory chronic lymphocytic leukemia.
PMID 18334676·Blood·2008
3-trial
WP1066 disrupts Janus kinase-2 and induces caspase-dependent apoptosis in acute myelogenous leukemia cells.
PMID 18056455·Cancer Res·2007
8-other
The JAK-STAT pathway: a therapeutic target in hematological malignancies.
PMID 17168672·Curr Cancer Drug Targets·2006
6-review
Monoclonal antibodies in chronic lymphocytic leukemia.
PMID 17020457·Expert Rev Anticancer Ther·2006
6-review
Bendamustine in relapsed or refractory chronic lymphocytic leukemia.
PMID 16219556·Haematologica·2005
8-other
Current guidelines in defining therapeutic strategies.
PMID 15325704·Hematol Oncol Clin North Am·2004
6-review
Phase II study of alemtuzumab in chronic lymphoproliferative disorders.
PMID 12910522·Cancer·2003
3-trial
The clinical significance of tumor necrosis factor-alpha plasma level in patients having chronic lymphocytic leukemia.
PMID 12149200·Blood·2002
8-other
High levels of vascular endothelial growth factor receptor-2 correlate with shortened survival in chronic lymphocytic leukemia.
PMID 11309324·Clin Cancer Res·2001
8-other
Fludarabine, cyclophosphamide, mitoxantrone plus rituximab (FCM-R) in frontline CLL <70 Years.
PMID 19646755·Leuk Res·2010
3-trial
Effective treatment of acute promyelocytic leukemia with all-trans-retinoic acid, arsenic trioxide, and gemtuzumab ozogamicin.
PMID 19075265·J Clin Oncol·2009
8-other
Characteristics associated with important clinical end points in patients with chronic lymphocytic leukemia at initial treatment.
PMID 19224852·J Clin Oncol·2009
8-other
De novo deletion 17p13.1 chronic lymphocytic leukemia shows significant clinical heterogeneity: the M. D. Anderson and Mayo Clinic experience.
PMID 19414856·Blood·2009
4-observational
Chronic lymphocytic leukemia: treatment options for patients with refractory disease.
PMID 19536902·Cancer·2009
6-review
A phase 2 study of yttrium-90 ibritumomab tiuxetan (Zevalin) in patients with chronic lymphocytic leukemia.
PMID 19637351·Cancer·2009
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1515 HOLCOMBE BLVD, 77030-4009
HOUSTON, TX 77030 - Phone
- (713) 792-6161
Quick Facts
- NPI
- 1952497687
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 38
- Publications
- 20
Are you this provider?
Claim Your Profile